These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8991043)

  • 81. Current concepts review: heparin-induced thrombocytopenia.
    DiGiovanni CW
    Foot Ankle Int; 2008 Nov; 29(11):1158-67. PubMed ID: 19026215
    [No Abstract]   [Full Text] [Related]  

  • 82. [Protamin-sulfate in cardiac surgery: between Scilla and Haribda].
    Charnaia MA; Morozova IuA; Gladysheva VG
    Khirurgiia (Mosk); 2006; (12):45-9. PubMed ID: 17419491
    [No Abstract]   [Full Text] [Related]  

  • 83. [Heparin-induced thrombocytopenia].
    Koide M; Matsuo T
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):307-10. PubMed ID: 9833497
    [No Abstract]   [Full Text] [Related]  

  • 84. Cutaneous adverse events associated with heparin.
    Maldonado Cid P; Alonso de Celada RM; Noguera Morel L; Feito-Rodríguez M; Gómez-Fernández C; Herranz Pinto P
    Clin Exp Dermatol; 2012 Oct; 37(7):707-11. PubMed ID: 22998541
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Femoral neuropathy due to a spontaneous hematoma of the iliopsoas muscle during therapy with heparin-calcium].
    Casoni P; Dalla Valle R
    Acta Biomed Ateneo Parmense; 1994; 65(5-6):289-96. PubMed ID: 8592921
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Heparin-induced thrombocytopenia and thrombosis.
    Ananthasubramaniam K; Shurafa M; Prasad A
    Prog Cardiovasc Dis; 2000; 42(4):247-60. PubMed ID: 10661778
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.
    Collins R; Peto R; Baigent C; Sleight P
    N Engl J Med; 1997 Mar; 336(12):847-60. PubMed ID: 9062095
    [No Abstract]   [Full Text] [Related]  

  • 88. [What is guaranteed in fibrinolytic therapy of deep venous thrombosis?].
    Seifried E
    Internist (Berl); 1990 Nov; 31(11):689-97. PubMed ID: 2289854
    [No Abstract]   [Full Text] [Related]  

  • 89. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.
    Hirsh J
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):20-5. PubMed ID: 9399406
    [No Abstract]   [Full Text] [Related]  

  • 90. Heparin therapy: current regimens and principles of monitoring.
    Berry BR; Nantel S
    Postgrad Med; 1996 Jun; 99(6):64-6, 69-76. PubMed ID: 8668639
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines.
    Gurbuz AT; Elliott WG; Zia AA
    Eur J Cardiothorac Surg; 2005 Jan; 27(1):138-49. PubMed ID: 15621486
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Pathogenesis and clinical practice of heparin-induced thrombocytopenia and thrombosis].
    Matsuo T
    Rinsho Ketsueki; 2007 Jan; 48(1):9-18. PubMed ID: 17313072
    [No Abstract]   [Full Text] [Related]  

  • 93. [Hypereosinophilia after calcium heparinate].
    Mouton Schleifer D; Chassaing S; Caron F; Borg JY; Bouchart F; Soyer R
    Presse Med; 1996 Nov; 25(37):1848. PubMed ID: 8991043
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.